Chengtian Technology (程天科技)
About
About Chengtian Technology (程天科技)
RoboCT's lower-limb exoskeletons use powered hip and knee joints to guide patients through repeatable walking patterns. Sensors estimate gait phase and user intent, allowing the controller to adjust assistance around people recovering from stroke, spinal-cord injury and other neurological or mobility impairments.
The product range covers clinical gait training, personal mobility and elderly assistance, supported by evaluation software and cloud-based rehabilitation data. Therapists can configure walking parameters and review progress across sessions, while Chengtian develops the actuators, control algorithms and human-machine interaction system underlying the exoskeletons.
Products
Funding
- 2026-03-05 - Series B+ - Chengtian Technology completes B+ financing round
source: 36kr.com
- 2026-03-05 - Series B+ - Chengtian Technology completes CNY100M-level Series B+
Chengtian Technology completed a CNY100 million-level Series B+ led by ABC Capital, with Inovance Industry Investment and Hangzhou Capital participating. - source: shangdaovc.icoc.me
- 2025-03-27 - Series B - $14.1M - Chengtian Technology (程天科技) completes near-RMB 100M Series B financing
source: m.36kr.com
- 2021-03-30 - Series A - Chengtian Technology (程天科技) raises Round A financing
source: equalocean.com
Investors
- ABC Capital - Lead - VC - 2 funding events - repeat backer - first seen 2026-03-05
- Hangzhou Capital - Participant - VC - 2 funding events - repeat backer - first seen 2026-03-05
- Inovance Industry Investment - Participant - Unknown - 2 funding events - repeat backer - first seen 2026-03-05
- Agricultural Bank Capital - Lead - VC - 1 funding event - first seen 2026-03-05
- LanChi Ventures - Lead - VC - 1 funding event - first seen 2021-03-30
- Wuxi Venture Capital - Lead - VC - 1 funding event - first seen 2025-03-27
Team
- Wang Tian - Founder and CEO - Wang leads RoboCT's exoskeleton robotics and embodied-intelligence work.
Timeline
Events
- 2026-09-14 - Demonstration - RoboCT exoskeleton range enters Northern Malaysia evaluations
The regional programme expands Robotimize’s RoboCT activity beyond the Klang Valley and presents multiple devices for adult, paediatric and elderly mobility needs. Clinicians and caregivers are evaluating how the systems fit existing rehabilitation programmes and care pathways. The activity is an introduction and evaluation programme; product use remains subject to local clinical requirements and applicable regulatory approvals.
Source - 2026-03-05 - Funding - Chengtian Technology completes B+ financing round
Chengtian Technology announced completion of a B+ financing round described as worth more than RMB 100 million. The round was led by ABC Capital, with participation from Inovance Industry Investment and Hangzhou Capital. Funding will support consumer-market expansion, embodied-intelligence exoskeleton R&D, BCI product registration, and channel network development.
Source - 2026-03-05 - Funding - Chengtian Technology completes CNY100M-level Series B+
The financing was Chengtian Technology's second completed round within one year. Proceeds support consumer-exoskeleton expansion and R&D in embodied-intelligence exoskeleton technology. The capital also supports product registration and channel development for the company's brain-computer-interface products.
Source - 2025-04-01 - Product Launch - Chengtian Technology (程天科技) launches EasyGo consumer exoskeleton and sells out first batch
Chengtian launched the EasyGo consumer exoskeleton product at a price of around RMB 2,500 Coverage says the first batch of several hundred units sold out in 15 seconds The launch marked a move from medical and institutional exoskeleton applications toward consumer mobility scenarios
Source - 2025-03-27 - Funding - Chengtian Technology (程天科技) completes near-RMB 100M Series B financing
Chengtian Technology announced completion of a near-RMB 100M Series B financing round Wuxi Venture Capital was reported as lead investor, with Houyue Capital serving as exclusive financial advisor Proceeds were earmarked for embodied-intelligence exoskeleton R&D, product iteration, and market expansion
Source - 2021-03-30 - Funding - Chengtian Technology (程天科技) raises Round A financing
EqualOcean reported that Chengtian Technology obtained tens of millions of RMB in Round A financing The company was described as an exoskeleton robot technology developer The report linked the round to expansion of a rehabilitation-oriented service model
Source
Context
Comparable profiles
- Wandercraft
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Wearable Robotics
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- CYBERDYNE
comparable profile - Medical Exoskeletons
- Ekso Bionics
comparable profile - Medical Exoskeletons
- Myomo
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Fourier Intelligence
comparable profile - Medical Exoskeletons
- Ottobock
comparable profile - Medical Exoskeletons · Rehab Exoskeleton Builder
- Marsi Bionics
comparable profile - Medical Exoskeletons
- Trexo Robotics
comparable profile - Medical Exoskeletons
Shared workflows
- REEV
workflow adjacency - Rehabilitation Robotics
- Reactive Robotics
workflow adjacency - Rehabilitation Robotics
- Human Robotix
workflow adjacency - Rehabilitation Robotics
- Humotech
workflow adjacency - Rehabilitation Robotics
Context tags
- Wearable rehab robot OEM - Stack Layer - RoboCT builds complete wearable rehab exoskeleton systems.
- Rehab exoskeleton builder - Peer Group - RoboCT builds rehabilitation exoskeletons for medical therapy.
- Medical exoskeletons - Peer Group - RoboCT exoskeletons serve medical rehabilitation applications.
- Gait rehabilitation - Workflow - RoboCT UGO supports lower-limb walking rehabilitation.
- Powered limb assistance - Capability - RoboCT provides powered limb assistance for rehab therapy.
- Rehabilitation robotics workflow - Workflow - RoboCT develops robotic rehabilitation systems.
- Rehabilitation robotics platform - Stack Layer - RoboCT provides rehabilitation robotics platforms.
- Intent-based motion control - Capability - RoboCT uses motion intent detection for exoskeleton control.
- Commercial deployment - Commercial Stage - RoboCT has commercial rehab exoskeleton deployments.
- Home assistive care - Customer Environment - RoboCT supports home and community assistive care use.
- Rehabilitation clinics - Customer Environment - RoboCT exoskeletons are used in rehabilitation clinics.